Impaired synaptic plasticity in mice carrying the Huntington's disease mutation
- PMID: 10196373
- DOI: 10.1093/hmg/8.5.839
Impaired synaptic plasticity in mice carrying the Huntington's disease mutation
Abstract
Cognitive impairment is an early symptom of Huntington's disease (HD). Mice engineered to carry the HD mutation in the endogenous huntingtin gene showed a significant reduction in long-term potentiation (LTP), a measure of synaptic plasticity often thought to be involved in memory. However, LTP could be induced in mutant slices by an 'enhanced' tetanic stimulus, implying that the LTP-producing mechanism is intact in mutant mice, but that their synapses are less able to reach the threshold for LTP induction. Mutant mice showed less post-tetanic potentiation than wild-type animals, and also showed decreased paired pulse facilitation, suggesting that excitatory synapses in HD mutant mice are impaired in their ability to sustain transmission during repetitive stimulation. We show that mutants, while normal in their ability to transmit at low frequencies, released significantly less glutamate during higher frequency synaptic activation. Thus, a reduced ability of Huntington synapses to respond to repetitive synaptic demand of even moderate frequency could result not only in a functional impairment of LTP induction, but could also serve as a substrate for the cognitive symptoms that comprise the early-stage pathology of HD.
Similar articles
-
Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation.J Neurosci. 2000 Jul 1;20(13):5115-23. doi: 10.1523/JNEUROSCI.20-13-05115.2000. J Neurosci. 2000. PMID: 10864968 Free PMC article.
-
Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease.J Neurosci. 2007 Apr 18;27(16):4424-34. doi: 10.1523/JNEUROSCI.5113-06.2007. J Neurosci. 2007. PMID: 17442827 Free PMC article.
-
Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease.Hum Mol Genet. 2006 May 15;15(10):1690-703. doi: 10.1093/hmg/ddl092. Epub 2006 Apr 6. Hum Mol Genet. 2006. PMID: 16600988
-
Huntington's disease: a synaptopathy?Trends Mol Med. 2003 Oct;9(10):414-20. doi: 10.1016/j.molmed.2003.08.006. Trends Mol Med. 2003. PMID: 14557053 Review.
-
Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease.Neuroscience. 2013 Oct 22;251:66-74. doi: 10.1016/j.neuroscience.2012.05.043. Epub 2012 May 24. Neuroscience. 2013. PMID: 22633949 Review.
Cited by
-
Structural Plasticity of the Hippocampus in Neurodegenerative Diseases.Int J Mol Sci. 2022 Mar 20;23(6):3349. doi: 10.3390/ijms23063349. Int J Mol Sci. 2022. PMID: 35328770 Free PMC article. Review.
-
Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice.J Neurosci. 2001 Nov 1;21(21):8473-81. doi: 10.1523/JNEUROSCI.21-21-08473.2001. J Neurosci. 2001. PMID: 11606636 Free PMC article.
-
Cholesterol metabolism in Huntington disease.Nat Rev Neurol. 2011 Sep 6;7(10):561-72. doi: 10.1038/nrneurol.2011.132. Nat Rev Neurol. 2011. PMID: 21894212 Review.
-
Long-Term Potentiation at CA3-CA1 Hippocampal Synapses with Special Emphasis on Aging, Disease, and Stress.Front Aging Neurosci. 2011 May 20;3:7. doi: 10.3389/fnagi.2011.00007. eCollection 2011. Front Aging Neurosci. 2011. PMID: 21647396 Free PMC article.
-
Inhibition of Rho kinases enhances the degradation of mutant huntingtin.J Biol Chem. 2009 May 8;284(19):13153-64. doi: 10.1074/jbc.M809229200. Epub 2009 Mar 11. J Biol Chem. 2009. PMID: 19278999 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases